Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma

Overview of attention for article published in Frontiers in oncology, February 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 1 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 23,814 followers.

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma https://t.co/Gd6hU3Viix https://t.co/Wsubq1iYec

16 Feb 2023

Reply Repost Favourite

New research: Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma: This case report describes the occurrence of hyperbilirubinemia as a complication of metastatic melanoma. A… https://t.co/O36Fc1l

15 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.